Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM14B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDHR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C4orf47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTGER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929586 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP69 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLINT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBC1D9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INMT-FAM188B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PICALM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AMBRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on